Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer

By Hasui Y.   Marutsuka K.   Asada Y.   Osada Y.  

Urology, Vol. 47, Iss. 1, 1996-01 ,pp. : 34-37

Elsevier

Access to resources Recommend Favorite

Clinicopathological Features of Recurrence after Radical Cystectomy for Patients with Transitional Cell Carcinoma of the Bladder

By Harada Ken-ichi   Sakai Iori   Kurahashi Toshifumi   Muramaki Mototsugu   Yamanaka Kazuki   Hara Isao   Eto Hiroshi   Miyake Hideaki  

International Urology and Nephrology, Vol. 38, Iss. 1, 2006-02 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Significance of Coexpression of Urokinase-type Plasminogen Activator, and Matrix Metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in Colorectal Carcinoma

By Inuzuka K.   Ogata Y.   Nagase H.   Shirouzu K.  

Journal of Surgical Research, Vol. 93, Iss. 2, 2000-10 ,pp. : 211-218

Academic Press

Access to resources Recommend Favorite

Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder

By May M.   Nitzke T.   Helke C.   Vogler H.   Hoschke B.  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 3, 2004-05 ,pp. : 231-235

Informa Healthcare

Access to resources Recommend Favorite

Size and volume of metastatic and non-metastatic lymph nodes in pelvis and lower abdomen in patients with carcinoma of the bladder undergoing radical cystectomy

By Jensen Jørgen Bjerggaard   Ulhøi Benedicte Parm   Jensen Klaus Møller-Ernst  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 5, 2010-11 ,pp. : 291-297

Informa Healthcare

Access to resources Recommend Favorite